Relacorilant is a selective glucocorticoid receptor modulator (SGRM) indicated for use in combination with chemotherapy for the treatment of platinum-resistant epithelial ovarian, fallopian tube, or primary… Read more
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) indicated for use in combination with chemotherapy for the treatment of platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. This category includes essential reference standards, such as stable isotope labelled compounds like Relacorilant-d4, which serve as vital internal standards for precise quantification in LC-MS/MS bioanalytical assays. Pharmaceutical laboratories and research organizations utilize these high-quality compounds, including the M4 and M9 metabolites, for comprehensive impurity profiling and rigorous method validation throughout drug development and quality control processes. These analytical tools enable the accurate characterization of drug metabolic pathways and the detection of degradation products, supporting the necessary compliance and consistency required in pharmaceutical analysis.